BILLS-116hr4850ih.pdf
House Resolutions
0 pages
Page
of 0
Loading OCR text...
No OCR text available for this page.
Failed to load OCR text.
DATE (8)
02:36 Oct 30, 2019
March 23, 2020
30 days
14
day
OCTOBER 23, 2019
1ST SESSION H. R. 4850
35
GENERAL.—Within 1 year
EVENT (1)
the ‘‘Biologic Patent
FAC (8)
PO 00000
Frm 00005
PO 00000
Frm 00006
PO 00000
Frm 00007
PO 00000
Frm 00003
Fmt
PO 00000
Frm 00001
PO 00000
Frm 00004
PO 00000
Frm 00008
Fmt
PO 00000
Frm 00002
GPE (3)
the United States Patent
the United States of America
the United States
NORP (1)
Cosmetic
ORG (15)
the Federal Food, Drug
uct
the Committee on Energy and Commerce
Federal Food, Drug
U.S.C.
THE HOUSE OF REPRESENTATIVES
CONGRESS
SEC
Trademark Office
the Public Health Service
the Committee on the Judiciary
Senate
the Public Health Service Act
House of Representa-
PERSON (3)
kjohnson
SPANBERGER
REED
Topic Classifications
congressional legislation
98.7%
public health
78.4%
government oversight
56.3%
Extracted Keywords
biological product
patent
biological
holder
product
disclosed
requirements respect
bio
additional requirements
approved
trans parency
parency
license
list
licensure
Forensic Analysis
PDF Metadata
- Creator
- ACOMP.exe WinVer 2.2a Sep 11 2014
- ModDate
- D:20230101200845Z
- Producer
- Acrobat Distiller 19.0 (Windows); modified using iText® Core 7.2.3 (production version) ©2000-2022 iText Group NV, Government Publishing Office
- CreationDate
- D:20191102000936-04'00'
Sentiment
Polarity
Neutral
0.074
Subjectivity
33%
Objective